Aardvark Therapeutics, Inc. Common Stock (AARD) is a publicly traded Healthcare sector company. As of May 21, 2026, AARD trades at $4.43 with a market cap of $95.12M and a P/E ratio of -1.33. AARD moved -1.49% today. Year to date, AARD is -67.70%; over the trailing twelve months it is -61.00%. Its 52-week range spans $3.35 to $19.58. Analyst consensus is buy with an average price target of $15.14. Rallies surfaces AARD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aardvark Therapeutics, Inc. Common Stock (AARD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AARD moved -1.49% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.43 |
| Market Cap | $95.12M |
| P/E Ratio | -1.33 |
| EPS | $-3.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.58 |
| 52-Week Low | $3.35 |
| Volume | 153.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $-1.18M |
| Net Income | $-69.87M |
| Gross Margin | 0.00% |
10 analysts cover AARD: 0 strong buy, 5 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.14.